Post-HSCT graft failure due to refractory human cytomegalovirus successfully treated with haploidentical donor-derived immunoglobulins and stem cell graft infusion: A case report

BACKGROUND: Human cytomegalovirus (HCMV) remains an important cause of transplant-related morbidity and mortality. The incidence of HCMV recurrence in the donor seronegative (D-)/recipient seropositive (R+) group is significantly higher than in other serostatus combinations as a result of a lack of...

Descripción completa

Detalles Bibliográficos
Autores principales: Baldo, Francesco, Suárez, Nicolás M., Davison, Andrew J., Zanon, Davide, Barbi, Egidio, Maximova, Natalia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188265/
https://www.ncbi.nlm.nih.gov/pubmed/33577809
http://dx.doi.org/10.1016/j.antiviral.2021.105024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188265/
https://www.ncbi.nlm.nih.gov/pubmed/33577809
http://dx.doi.org/10.1016/j.antiviral.2021.105024

Ejemplares similares